Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ORTHOPEDIATRICS CORPKIDS · Entity 5338 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ORTHOPEDIATRICS CORP
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 179,317 |
Reported balance
After 2026-06-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 11,436 · Balance 179,317 F1: Includes restricted stock awards totaling 38,660 shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 22,497 |
Reported balance
Holding disclosure · report date 2026-06-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 22,497 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock awards totaling 38,660 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 10, 2026 09:49 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 11,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-26-000053 · wk-form4_1781099346.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,317 F1 · balance_after: Includes restricted stock awards totaling 38,660 shares. Read SEC document |
| May 23, 2025 Filed May 28, 2025 08:48 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 8,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000061 · wk-form4_1748436521.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,881 F1 · balance_after: Includes restricted stock awards totaling 42,290 shares. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 16:18 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 21,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000069 · wk-form4_1718137109.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,480 F1 · balance_after: Includes restricted stock awards totaling 44,252 shares. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 08:43 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 2,433 | $27.59 | $67,126.47 |
DisclosureSEC source: 0001425450-24-000022 · wk-form4_1710247398.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,857 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 22,629 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 16:30 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 12,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000047 · wf-form4_167891221922712.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,290 F1 · balance_after: Includes restricted stock awards totaling 27,906 shares. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 09:13 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 4,515 | $43.83 | $197,871.68 |
DisclosureSEC source: 0001425450-23-000030 · wf-form4_167819839045203.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,024 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 15,640 shares. Read SEC document |
| November 17, 2022 Filed Jan 10, 2023 11:50 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000006 · wf-form5_167336940764188.xml · nonDerivative · entry 2 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,539 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bone fide gift. F2 · balance_after: Includes restricted stock awards totaling 25,689 shares. Read SEC document |
| November 16, 2022 Filed Jan 10, 2023 11:50 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000006 · wf-form5_167336940764188.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,839 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bone fide gift. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 10:06 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 10,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000038 · wf-form4_164743956004892.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,139 F1 · balance_after: Includes restricted stock awards totaling 25,689 shares. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 14:22 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 5,961 | $58.60 | $349,314.60 |
DisclosureSEC source: 0001425450-22-000019 · wf-form4_164633532112388.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,776 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 15,326 shares. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 17:18 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-21-000157 · wf-form4_164012509387877.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,737 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bona fide gift. F2 · balance_after: Includes restricted stock awards totaling 29,572 shares. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 10:48 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 4,774 | $65.40 | $312,219.60 |
DisclosureSEC source: 0001425450-21-000114 · wf-form4_162808851878991.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,737 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 29,572 shares. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 11:38 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 15,226 | $65.88 | $1,003,088.88 |
DisclosureSEC source: 0001425450-21-000110 · wf-form4_162800511866210.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,511 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 29,572 shares. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 11:03 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 5,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-21-000038 · wf-form4_161478737249168.xml · nonDerivative · entry 2 Throdahl Mark C · CIK 0001439415 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,737 F2 · balance_after: Includes restricted stock awards totaling 29,572 shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 11:03 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 5,097 | $55.88 | $284,820.36 |
DisclosureSEC source: 0001425450-21-000038 · wf-form4_161478737249168.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,460 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 12:01 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 12,651 | $50.34 | $636,851.34 |
DisclosureSEC source: 0001425450-21-000017 · wf-form4_161289006020954.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,557 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 09:25 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 7,349 | $50.18 | $368,772.82 |
DisclosureSEC source: 0001425450-21-000015 · wf-form4_161253514388526.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,208 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 15:43 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 13,389 | $42.88 | $574,120.32 |
DisclosureSEC source: 0001425450-20-000096 · wf-form4_159345974281328.xml · nonDerivative · entry 2 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,557 F2 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F1 · balance_after: Includes restricted stock awards totaling 36,295 shares. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 15:43 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 30,000 | $44.08 | $1,322,400.00 |
DisclosureSEC source: 0001425450-20-000096 · wf-form4_159345974281328.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,946 F1 · balance_after: Includes restricted stock awards totaling 36,295 shares. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 402 | $30.97 Strike: $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · derivative · entry 12 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 402 shares Expires 2023-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 402 | $30.97 Strike: $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · derivative · entry 11 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 402 shares Expires 2022-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 402 | $30.97 Strike: $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · derivative · entry 10 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 402 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 670 | $30.97 Strike: $30.97 | $20,749.90 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · derivative · entry 9 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 670 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 402 | $46.57 | $18,721.14 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 8 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,946 Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 402 | $46.56 | $18,717.12 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 7 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,348 Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 402 | $46.56 | $18,717.12 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 6 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,750 Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 670 | $46.56 | $31,195.20 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 5 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,152 Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 402 | $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 4 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 402 | $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 3 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 402 | $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 2 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:27 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 670 | $30.97 | $20,749.90 |
DisclosureSEC source: 0001425450-20-000047 · wf-form4_159009283321781.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 14:45 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-20-000018 · wf-form4_158335110933939.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,946 F1 · balance_after: Includes restricted stock awards totaling 36,295 shares. Read SEC document |
| December 13, 2019 Filed Dec 13, 2019 13:22 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 10,000 | $34.31 | $343,100.00 |
DisclosureSEC source: 0001425450-19-000106 · wf-form4_157626133748037.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,897 F1 · kind: Shares sold in an underwritten public offering in which the Reporting Person was a selling stockholder. F2 · balance_after: Includes restricted stock awards totaling 26,246 shares. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 11:21 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-19-000074 · wf-form4_156078487530981.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,897 F1 · shares: Shares of OrthoPediatrics Corp common stock were given as a bona fide gift for no consideration. F2 · balance_after: Includes restricted stock awards totaling 26,246 shares subject to vesting requirements. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 09:18 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 14,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-19-000018 · wf-form4_155144990353130.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,897 F1 · balance_after: Includes restricted stock awards totaling 26,246 shares. Read SEC document |
| April 13, 2018 Filed Apr 16, 2018 15:34 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 27,549 | $17.92 | $493,678.08 |
DisclosureSEC source: 0001425450-18-000057 · wf-form4_152390720769178.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,651 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 15:39 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-18-000027 · wf-form4_151993674208926.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,200 F1 · balance_after: Includes restricted stock awards totaling 75,424 shares. Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 18:05 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | ConversionSeries B Convertible Preferred Stock · Derivative | 11,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-052686 · tv477019_4.xml · derivative · entry 3 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. F2 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. F2 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 18:05 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Tax withholdingCommon Stock | 31,082 | $13.00 | $404,066.00 |
DisclosureSEC source: 0001144204-17-052686 · tv477019_4.xml · nonDerivative · entry 2 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,200 F3 · shares: Represents shares delivered to the Issuer to satisfy tax withholdings in connection with the lapse of restrictions on 67,877 shares of restricted common stock. Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 18:05 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | ConversionCommon Stock | 7,640 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-052686 · tv477019_4.xml · nonDerivative · entry 1 Throdahl Mark C · CIK 0001439415 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares received upon conversion of the Series B Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering. F2 · price: Each share of Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.